Persistent CoughNCT05586035
Analysis of Factors and Treatment Related to Chronic Cough After Pulmonary Resection
An observational study of Persistent Cough and Pneumonectomy, run by Guangdong Provincial People's Hospital at 1 site in China.
Trial summary
Surgical resection is the primary treatment for pulmonary tumors. Surgeons has been frequently concerned about effectiveness, safety, and minimal invasive techniques. However, persistent cough, one of the most common complications of lung surgery, has received insufficient attention. Read more about this study
- Who is it for?
- Ages 18 to 85 yearsHealthy volunteers can take part
- Conditions the study is for
- Persistent Cough, Pneumonectomy, Lung Neoplasms
- How many people
- 300 participants
- Where
- 1 siteChina
- Study dates
- 2 Sep 2021to 30 Aug 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 85 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients underwent pulmonary resection in Guangdong Provincial People's Hospital and Shenzhen People's Hospital were eligible for this study.
Who may be able to join
- Patients who received pulmonary resection;
- 18-to 85-year-old;
- Pathologically diagnosed as NSCLC or benign tumor.
Who cannot join
- Multiple malignancy in other parts of body;
- Refuse to participate in this study;
- Other situations evaluated by investigators not meet the enrollment.
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080
Guibin Qiao, M.D., Ph.D., 13602749153, guibinqiao@126.com
About this study
Surgical resection is the primary treatment for pulmonary tumors. Surgeons has been frequently concerned about effectiveness, safety, and minimal invasive techniques. However, persistent cough, one of the most common complications of lung surgery, has received insufficient attention. This study set out to investigate the risk factors and treatment related to persistent cough after pulmonary resection.
- Conditions
- Persistent Cough, Pneumonectomy, Lung Neoplasms
- Medical subject headings
- Chronic Cough, Lung Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
Occurence rate of persistent cough after pulmonary resection
Occurence rate of persistent cough after pulmonary resection
Measured: Persistent cough after pulmonary resection is monitored from the time of surgery, up to 12 months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Oct 2022
- Study start2 Sep 2021
- Primary completion30 Dec 2022 (estimated)
- Study completion30 Aug 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Persistent CoughStudies of the same condition, open and under way.
- More trials run by Guangdong Provincial People's HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Guangdong Provincial People's Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- The People's Hospital of Gaozhou, Shenzhen People's Hospital
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05586035
- Sponsor's protocol ID
- KY-Q-2022-007
- Status last verified
- Oct 2022
- First submitted
- 16 Oct 2022
- Last updated
- 19 Oct 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Analysis of Factors and Treatment Related to Chronic Cough After Pulmonary Resection
- ClinicalTrials.gov ID
- NCT05586035
- Acronym / sponsor ID
- KY-Q-2022-007
- Conditions
- Persistent Cough, Pneumonectomy, Lung Neoplasms
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Guangdong Provincial People's HospitalUniversity, hospital or other
- Collaborators
- The People's Hospital of Gaozhou, Shenzhen People's Hospital
- Study start
- 2 Sep 2021 (actual)
- Primary completion
- 30 Dec 2022 (estimated)
- Study completion
- 30 Aug 2023 (estimated)
- First posted
- 19 Oct 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Surgical resection is the primary treatment for pulmonary tumors. Surgeons has been frequently concerned about effectiveness, safety, and minimal invasive techniques. However, persistent cough, one of the most common complications of lung surgery, has received insufficient attention. This study set out to investigate the risk factors and treatment related to persistent cough after pulmonary resection.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 85 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients underwent pulmonary resection in Guangdong Provincial People's Hospital and Shenzhen People's Hospital were eligible for this study.
Key inclusion criteria (3 listed)
- Patients who received pulmonary resection;
- 18-to 85-year-old;
- Pathologically diagnosed as NSCLC or benign tumor.
Key exclusion criteria (3 listed)
- Multiple malignancy in other parts of body;
- Refuse to participate in this study;
- Other situations evaluated by investigators not meet the enrollment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Occurence rate of persistent cough after pulmonary resection
Time frame: Persistent cough after pulmonary resection is monitored from the time of surgery, up to 12 months.
Occurence rate of persistent cough after pulmonary resection
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Oct 2022.
Related trials for Persistent Cough
Not yet recruiting
Effects of Energy Versus Mechanical Surgical Devices on Postoperative Cough
Postoperative Cough, Cough Hypersensitivity Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Persistent Cough and Pneumonectomy, run by Guangdong Provincial People's Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 19 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Guibin Qiao, M.D., Ph.D. (13602749153 ext. 86, guibinqiao@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Occurence rate of persistent cough after pulmonary resection (time frame: Persistent cough after pulmonary resection is monitored from the time of surgery, up to 12 months.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2022.